SAREPTA THERAPEUTICS, INC. Assets Held-for-sale, Long Lived (Deprecated 2014-01-31)
SAREPTA THERAPEUTICS, INC. (SRPT) had Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) of $1.86 million as of 2011-09-30, per its 10-Q filed 2011-11-08.
Discontinued › Notes
us-gaap:AssetsHeldForSaleLongLived · last filed 2012-03-13
- 2011-09-30: Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) $1.86M.
- 2011-06-30: Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) $1.97M.
- 2010-12-31: Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) $1.97M.
| Period end | Assets Held-for-sale, Long Lived (Deprecated 2014-01-31) |
|---|---|
| 2011-09-30 | $1.86M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $1.97M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $1.97M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |